Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics
Michał Lis, Bartłomiej Stańczykiewicz, Paweł Liśkiewicz, et al.
Psychoneuroendocrinology (2020) Vol. 119, pp. 104744-104744
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
Yutaka Mizuki, Shinji Sakamoto, Yuko Okahisa, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 5, pp. 367-382
Open Access | Times Cited: 62
Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis
Błażej Misiak, Bartłomiej Stańczykiewicz, Michał Wiśniewski, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110402-110402
Open Access | Times Cited: 48
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Raghunath Singh, Nicolette Stogios, Emily R. Smith, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 31
Gut microbiota alterations in schizophrenia might be related to stress exposure: Findings from the machine learning analysis
Paweł Karpiński, Paulina Żebrowska-Różańska, Dorota Kujawa, et al.
Psychoneuroendocrinology (2023) Vol. 155, pp. 106335-106335
Open Access | Times Cited: 17
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 25
Profiling gut microbiota signatures associated with the deficit subtype of schizophrenia: Findings from a case-control study
Krzysztof Kowalski, Paulina Żebrowska-Różańska, Paweł Karpiński, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 127, pp. 110834-110834
Closed Access | Times Cited: 13
Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players
Juan D. Molina, Sonia Avila, Gabriel Rubio, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 39, pp. 4049-4061
Open Access | Times Cited: 28
Exploring Patterns of Disturbed Eating in Psychosis: A Scoping Review
Nicolette Stogios, Emily R. Smith, Roshanak Asgariroozbehani, et al.
Nutrients (2020) Vol. 12, Iss. 12, pp. 3883-3883
Open Access | Times Cited: 30
Prevalence of Eating Disorders in Individuals With Schizophrenia Spectrum Disorder: A Systematic Review and Meta‐Analysis
Swastik Subhankar Sahu, Mahalaqua Nazli Khatib, Rekha MM, et al.
European Eating Disorders Review (2025)
Closed Access
Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain
Jing Lü, Manli Huang, Jinhui Li, et al.
Schizophrenia Bulletin (2021) Vol. 47, Iss. 5, pp. 1310-1319
Open Access | Times Cited: 20
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management
Gianluca Sesso, Giulio Emilio Brancati, Gabriele Masi
Current Neuropharmacology (2022) Vol. 21, Iss. 4, pp. 911-934
Open Access | Times Cited: 13
Individualized functional connectome identified generalizable biomarkers for psychiatric symptoms in transdiagnostic patients
Meiling Li, Louisa Dahmani, Catherine S. Hubbard, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 4, pp. 633-641
Open Access | Times Cited: 11
Association between free thyroxine levels and clinical phenotype in first-episode psychosis: a prospective observational study
Eloi Giné-Servén, M.J. Martínez-Ramírez, Ester Boix-Quintana, et al.
PeerJ (2023) Vol. 11, pp. e15347-e15347
Open Access | Times Cited: 6
Adipose tissue dysregulation at the onset of psychosis: Adipokines and social determinants of health
Franz Veru, Stéphane Guay, Jai Shah, et al.
Psychoneuroendocrinology (2020) Vol. 123, pp. 104915-104915
Open Access | Times Cited: 10
Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study
Mikel Tous‐Espelosin, Sonia Ruiz de Azúa, Nagore Iriarte‐Yoller, et al.
Psychiatry Research (2020) Vol. 295, pp. 113580-113580
Closed Access | Times Cited: 7
New Personality and Neurocommunication: Neurogenetics and Neural Networks, Psychoneuroimmunoendocrinology, 5P Medicine and 5G Technologies
С. В. Булгакова, N. Romanchuk, А. Н. Волобуев
Bulletin of Science and Practice (2021) Vol. 7, Iss. 8, pp. 202-240
Open Access | Times Cited: 6
Metformin acts on the gut-brain axis to ameliorate antipsychotic-induced metabolic dysfunction
Xiaorong Wang, Huimin Huang, Yiyi Zhu, et al.
BioScience Trends (2021) Vol. 15, Iss. 5, pp. 321-329
Open Access | Times Cited: 6
As We Were and as We Should Be, Combined Exercise Training in Adults with Schizophrenia: CORTEX-SP Study Part I
Mikel Tous‐Espelosin, Sonia Ruiz de Azúa, N Iriarte-Yoller, et al.
Medicine & Science in Sports & Exercise (2023)
Closed Access | Times Cited: 2
Sleep Apnea in Schizophrenia: Estimating Prevalence and Impact on Cognition
Stephen Edward Ghazikhanian, Toral Surti
Journal of Psychiatric Research (2024) Vol. 177, pp. 330-337
Closed Access
Antipsychotic‐Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia‐Related Obesity
Emre Sarandöl, Aslı Sarandöl, Mesut Şener, et al.
Human Psychopharmacology Clinical and Experimental (2024) Vol. 39, Iss. 6
Open Access
Uncovering Nesfatin-1 and Irisin Hormones in Schizophrenia and Psychosis Patients: A Comparative Investigation
Erhan H. Dincer, Şermin Algül, Oğuz Özçelik
Biomarkers in Neuropsychiatry (2024) Vol. 11, pp. 100112-100112
Open Access
Association of higher plasma leptin levels with HOMA-IR index, high sensitivity C-reactive protein and glycolipid metabolism in patients with chronic schizophrenia: A multi-center cross-sectional study
Zhiwei Liu, Yulong Zhang, Juan Wang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 2
Peer Review #2 of "Association between free thyroxine levels and clinical phenotype in first-episode psychosis: a prospective observational study (v0.1)"
Gopi Kumbha
(2023)
Open Access
Peer Review #1 of "Association between free thyroxine levels and clinical phenotype in first-episode psychosis: a prospective observational study (v0.1)"

(2023)
Open Access
Peer Review #2 of "Association between free thyroxine levels and clinical phenotype in first-episode psychosis: a prospective observational study (v0.2)"
Gopi Kumbha
(2023)
Open Access
Page 1 - Next Page

Scroll to top